Study of Chronic Myelomonocytic Leukemia in Adults
Part of Blood & lymphatic, Cancer clinical trials.
This research study collects information from adults with chronic myelomonocytic leukemia (CMML), a rare blood cancer where the body makes too many monocytes (a type of white blood cell). By following patients over time, researchers aim to better understand the disease and improve treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with chronic myelomonocytic leukemia, OR you have high monocyte levels (≥0.5 × 10⁹/L and ≥10% of total white blood cells)
- You are willing to sign an informed consent form agreeing to participate
- You do not have an active, uncontrolled infection, particularly hepatitis B, hepatitis C, or HIV
- Your CMML can be at any stage (early or advanced) and you may or may not be receiving treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study examines blood cells from patients with chronic myelomonocytic leukemia (CMML), a rare blood cancer, to better understand how the disease develops and progresses. By studying your blood cells, researchers hope to learn more about what causes CMML and how to treat it better.
This study looks at certain immune cells called macrophages in the bone marrow of people with chronic myelomonocytic leukemia (CMML). It aims to better understand the disease, which may help improve treatments in the future.
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
This study looks at how chronic myeloid leukemia (CML) affects your daily life and how care is organized in Lombardy hospitals. Researchers want to learn from your experiences to improve care for everyone with CML.
This is a registry (a study that collects health information over time) for adults with suspected or confirmed blood cancers of the myeloid type. It aims to better understand the biology of these illnesses and how different factors affect outcomes, which may improve care in the future.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.